Historically, the absence of FDA-approved treatments specifically targeting NASH has left many patients and healthcare providers with limited options, often focusing on lifestyle changes with ...

The authors recommend that large controlled trials of extended duration should be performed to establish the long-term safety and efficacy of pioglitazone as a treatment for NASH.